Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription 20.05.2024 3 BMJ 1 Clin Infect Dis 1 J Infect 5 J Infect Dis 3 J Virol 2 JAMA 2 MMWR Morb Mortal Wkly Rep 1 Nat Med 2 Pediatr Infect Dis J 2 Pediatrics 6 PLoS One 3 Science 13 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. WISE J
   Whooping cough: What's behind the rise in cases and deaths in England?
   BMJ. 2024;385:q1118.
   PubMed        
   
   
2. AMBOREE TL, Paguio J, Sonawane K
   HPV vaccine: the key to eliminating cervical cancer inequities.
   BMJ. 2024;385:q996.
   PubMed        
   
   
3. FALCARO M, Soldan K, Ndlela B, Sasieni P, et al
   Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.
   BMJ. 2024;385:e077341.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

4. USDAN L, Patel S, Rodriguez H, Xu X, et al
   A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in >/=12-Year-Olds.
   Clin Infect Dis. 2023 Nov 28:ciad718. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Infect

5. AMANO M, Ichikawa Y, Matsumoto S, Higashi-Kuwata N, et al
   Neutralization activity of HCWs' sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination.
   J Infect. 2024;89:106179.
   PubMed        
   
   

   
   J Infect Dis

6. SMITH CL, Didion E, Aung H, Tamilselvan B, et al
   Longitudinal analysis of nursing home residents' T cell responses after SARS-CoV-2 mRNA vaccinations shows influence of biological sex and SARS-CoV-2 infection history.
   J Infect Dis. 2024 May 14:jiae234. doi: 10.1093.
   PubMed         Abstract available
   
   
7. MOTSOENENG BM, Dhar N, Nunes MC, Krammer F, et al
   Hemagglutinin stalk-specific Fc-mediated functions are associated with protection against influenza-illness after seasonal influenza vaccination in pregnant women.
   J Infect Dis. 2024 May 14:jiae241. doi: 10.1093.
   PubMed         Abstract available
   
   
8. BLAZEVIC A, Edwards RL, Xia M, Eickhoff CS, et al
   Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guerin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.
   J Infect Dis. 2023 Nov 29:jiad441. doi: 10.1093.
   PubMed         Abstract available
   
   
9. NJIFON HLM, Kenmoe S, Ahmed SM, Roussel Takuissu G, et al
   Epidemiology of Rotavirus in Humans, Animals, and the Environment in Africa: A Systematic Review and Meta-analysis.
   J Infect Dis. 2024;229:1470-1480.
   PubMed         Abstract available
   
   
10. LEE YS, Bang YJ, Yoo S, Park SI, et al
    Analysis of the Immunostimulatory Effects of Cytokine-Expressing Internal Ribosome Entry Site-Based RNA Adjuvants and Their Applications.
    J Infect Dis. 2024;229:1408-1418.
    PubMed         Abstract available
    
    

    
    J Virol

11. PEREZ DR
    A devastating blow: personal reflections on Argentina's scientific decline.
    J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
    PubMed         Abstract available
    
    
12. ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
    Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
    J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
    PubMed         Abstract available
    
    
13. ZHU Z, Han Y, Gong M, Sun B, et al
    Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
    J Virol. 2024 Apr 1:e0195723. doi: 10.1128/jvi.01957.
    PubMed         Abstract available
    
    

    
    JAMA

14. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    PubMed        
    
    
15. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

16. GEIGER K, Stehling-Ariza T, Bigouette JP, Bennett SD, et al
    Progress Toward Poliomyelitis Eradication - Worldwide, January 2022-December 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:441-446.
    PubMed         Abstract available
    
    
17. GRESSICK K, Nham A, Filardo TD, Anderson K, et al
    Measles Outbreak Associated with a Migrant Shelter - Chicago, Illinois, February-May 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:424-429.
    PubMed         Abstract available
    
    

    
    Nat Med

18. MENTZER AJ, Dilthey AT, Pollard M, Gurdasani D, et al
    High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response.
    Nat Med. 2024 May 13. doi: 10.1038/s41591-024-02944.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

19. 
    Multisystem Inflammatory Syndrome in Children Among Persons Who Completed a Two-dose COVID-19 Vaccine Primary Series Compared With Those Reporting No COVID-19 Vaccination, US National MIS-C Surveillance: ERRATUM.
    Pediatr Infect Dis J. 2024;43:186.
    PubMed        
    
    
20. BANDYOPADHYAY AS, Burke RM, Hawes KM
    Polio Eradication: Status, Struggles and Strategies.
    Pediatr Infect Dis J. 2024;43:e207-e211.
    PubMed        
    
    

    
    Pediatrics

21. SCHNYDER GHAMLOUSH S, Essink B, Hu B, Kalidindi S, et al
    Safety and Immunogenicity of an mRNA-Based hMPV/PIV3 Combination Vaccine in Seropositive Children.
    Pediatrics. 2024 May 13:e2023064748. doi: 10.1542/peds.2023-064748.
    PubMed         Abstract available
    
    
22. ATMAR RL, El Sahly HM
    The Promise of New Vaccines Against Respiratory Viruses.
    Pediatrics. 2024 May 13:e2023065328. doi: 10.1542/peds.2023-065328.
    PubMed        
    
    

    
    PLoS One

23. GICHUKI J, Ngoye B, Wafula F
    "I'll take them another day": A qualitative study exploring the socio-behavioral complexities of childhood vaccination in urban poor settlements.
    PLoS One. 2024;19:e0303215.
    PubMed         Abstract available
    
    
24. YASEEN A, DeSantis SM, Sabharwal R, Talebi Y, et al
    Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.
    PLoS One. 2024;19:e0303420.
    PubMed         Abstract available
    
    
25. WASSIE GT, Ambelie YA, Adebabay T, Yeshiwas AG, et al
    Covid-19 vaccine uptake and its associated factors among adult population in Dangila district, Awi Zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2024;19:e0302531.
    PubMed         Abstract available
    
    
26. KHEZRI M, McKnight C, Weng CA, Kimball S, et al
    COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
    PLoS One. 2024;19:e0303394.
    PubMed         Abstract available
    
    
27. URAZAYEVA ST, Kurmangaliyeva SS, Kaliyev AA, Tussupkaliyeva KS, et al
    Attitude toward vaccination against COVID-19 and acceptance of the national "QazVac" vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey.
    PLoS One. 2024;19:e0303854.
    PubMed         Abstract available
    
    
28. MOIN AT, Rani NA, Patil RB, Robin TB, et al
    In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxviruses.
    PLoS One. 2024;19:e0300778.
    PubMed         Abstract available
    
    

    
    Science

29. SANDERS RW, Moore JP
    Progress on priming HIV-1 immunity.
    Science. 2024;384:738-739.
    PubMed         Abstract available
    
    
30. XIE Z, Lin YC, Steichen JM, Ozorowski G, et al
    mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies.
    Science. 2024;384:eadk0582.
    PubMed         Abstract available
    
    
31. STEICHEN JM, Phung I, Salcedo E, Ozorowski G, et al
    Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.
    Science. 2024;384:eadj8321.
    PubMed         Abstract available
    
    

    
    Vaccine

32. GARCIA-VICENTE EJ, Rey-Casero I, Martin M, Perez A, et al
    Oral supplementation with postbiotics modulates the immune response produced by myxomatosis vaccination in wild rabbits.
    Vaccine. 2024 May 16:S0264-410X(24)00585-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
33. URAGUCHI K, Matsumoto N, Mitsuhashi T, Takao S, et al
    Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010.
    Vaccine. 2024 May 16:S0264-410X(24)00567-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
34. NG'OMBE H, Bosomprah S, Phiri B, Muchimba M, et al
    Comparative analysis of cholera serum vibriocidal antibodies from Convalescent and vaccinated adults in Zambia.
    Vaccine. 2024 May 16:S0264-410X(24)00587-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
35. RAMOS-DUARTE VA, Orlowski A, Jaquenod de Giusti C, Corigliano MG, et al
    Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen.
    Vaccine. 2024;42:3355-3364.
    PubMed         Abstract available
    
    
36. CARNALLA M, Stern D, Arantxa Colchero M, Rangel-Moreno K, et al
    Who is getting COVID-19 boosters? A latent class analysis in a nationally representative sample of Mexican adults 60 years and over.
    Vaccine. 2024;42:3273-3276.
    PubMed         Abstract available
    
    
37. LEE KY, Song KH, Lee KH, Baek JY, et al
    Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection.
    Vaccine. 2024 May 9:S0264-410X(24)00539-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
38. SHANI M, Hermesh I, Feldhamer I, Reges O, et al
    The association between BNT162b2 vaccinations and incidence of immune-mediated comorbidities.
    Vaccine. 2024 May 9:S0264-410X(24)00536-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
39. MALTEZOU HC, Gamaletsou MN, Giannouchos TV, Koukou DM, et al
    Effectiveness of COVID-19 booster vaccination, morbidity and absenteeism among healthcare personnel during the 2022-2023 season dominated by Omicron BA.5 and BA.2 subvariants.
    Vaccine. 2024 May 9:S0264-410X(24)00522-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
40. DINH THIEM V, Van Anh PT, Van Men C, Hung DT, et al
    A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial.
    Vaccine. 2024 May 10:S0264-410X(24)00523-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
41. LIU F, Li Z, Wang H, Cao Y, et al
    Effectiveness of the varicella vaccine in the real world, a matched case-control study.
    Vaccine. 2024 May 10:S0264-410X(24)00552-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
42. KARIM S, Rehana Siddiqui A, Karim N, Pradhan NA, et al
    Role of rotavirus vaccine in reducing diarrheal episodes in infants visiting private primary health care clinics in Karachi, Pakistan: A mixed-methods study.
    Vaccine. 2024 May 13:S0264-410X(24)00558-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
43. MUANGNOICHAROEN S, Wiangcharoen R, Lawpoolsri S, Nanthapisal S, et al
    Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial.
    Vaccine. 2024 May 13:S0264-410X(24)00556-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
44. URQUIDI C, Sepulveda-Penaloza A, Valenzuela MT, Ponce A, et al
    Vaccine effectiveness in reducing COVID-19-related hospitalization after a risk-age-based mass vaccination program in a Chilean municipality: A comparison of observational study designs.
    Vaccine. 2024 May 14:S0264-410X(24)00538-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

    
    Virology

45. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
    Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
    Virology. 2024;595:110082.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.